Benjamin Rovinski
Director/Board Member at Life Sciences Ontario
Network origin in Benjamin Rovinski first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Ontario Genomics Institute (Private Equity)
 Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London.
29
| Subsidiary | Investment Managers | 29 |
| Public Company | Biotechnology | 23 | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.
16
| Subsidiary | Investment Managers | 16 |
Iterion Therapeutics, Inc.
 Iterion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Iterion Therapeutics, Inc. provides pharmaceuticals services. The firm products are used in the treatment of colorectal, hematopoietic, and other targeted cancers. The company was founded by Jonathan P. Northrup in 2010 and is headquartered in Houston, TX.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA.
9
| Holding Company | Biotechnology | 9 |
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA.
8
| Private Company | Pharmaceuticals: Major | 8 |
Life Sciences Ontario
7
| Non-Profit Organization | 7 | |
Bright Angel Therapeutics, Inc.
 Bright Angel Therapeutics, Inc. BiotechnologyHealth Technology Bright Angel Therapeutics, Inc. is a pre-clinical stage biotechnology company. It is focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. The company is headquartered in Toronto, Canada.
1
| Holding Company | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Benjamin Rovinski via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member President | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Director/Board Member Sales & Marketing Chief Tech/Sci/R&D Officer | |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Investor Relations Contact | |
| DIAMEDICA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Corporate Secretary Chief Operating Officer | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Chief Executive Officer Private Equity Investor Private Equity Investor | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Doctorate Degree Masters Business Admin | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
| McGill University | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| Queen's University | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Alberta | College/University | Undergraduate Degree Graduate Degree | |
| University of British Columbia | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| University of Toronto | College/University | Masters Business Admin Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| The University of Waterloo | College/University | Corporate Officer/Principal Graduate Degree | |
| McMaster University | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| MANY BRIGHT IDEAS TECHNOLOGIES INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| Henley Management College | College/University | Doctorate Degree Masters Business Admin | |
Innovate BC
 Innovate BC Miscellaneous Commercial ServicesCommercial Services Innovate BC develops entrepreneurial talent and supports commercializing technology. The firm focuses on competitively positioning British Columbia in today's global knowledge economy in order to provide significant employment opportunities and a high standard of living for British Columbians. The company was founded in 1978 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman | |
| COTINGA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| Pasteur Mérieux Connaught | Corporate Officer/Principal General Counsel | ||
SHVMS, LLC
 SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | Investment Managers | Private Equity Investor Founder | |
| ATHERSYS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Ontario Centre of Innovation
 Ontario Centre of Innovation Financial ConglomeratesFinance Ontario Centres of Excellence, Inc. invests in research, commercialization & talent. The firm is a non-profit organization that drives the research to commercialization process. The company was founded in 2002 and is headquartered in Toronto, ON. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
ALUS Liquidation Corp.
 ALUS Liquidation Corp. Medical SpecialtiesHealth Technology ALUS Liquidation Corp. develops, manufactures, and sells medical products. The company is based in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| Richard Ivey School of Business | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kisoji Biotechnology, Inc.
 Kisoji Biotechnology, Inc. BiotechnologyHealth Technology Kisoji Biotechnology, Inc. operates as a biotechnology company which develops cancer therapeutics through antibodies and stem cells. The company was founded by David S. Young and is headquartered in Montreal, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
OsteoqQC, Inc.
 OsteoqQC, Inc. BiotechnologyHealth Technology OsteoqQC, Inc. develops drugs for the treatment of bone-related diseases. The company was founded by Debra Ellies and is headquartered in Montreal, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
| Western University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Specific Biologics, Inc.
 Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| LAVA MEDTECH ACQUISITION CORP. | Financial Conglomerates | President Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| United States | 27 |
| Canada | 21 |
| United Kingdom | 2 |
| Vietnam | 2 |
| Hong Kong | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 17 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 2 |
Operational
| Director/Board Member | 547 |
| Corporate Officer/Principal | 130 |
| Independent Dir/Board Member | 109 |
| Chairman | 75 |
| Chief Executive Officer | 74 |
Most connected contacts
| Insiders | |
|---|---|
| Raf Hofstein | 36 |
| Kurt von Emster | 34 |
| Brian Underdown | 34 |
| Nancy T. Chang | 31 |
| Wende Hutton | 31 |
| Peter Greenleaf | 31 |
| Thomas Wellner | 31 |
| David Kabakoff | 30 |
| Nicole Vitullo | 29 |
| Louis C. Bock | 27 |
| Michael Hayden | 27 |
| Richard Glickman | 26 |
| R. MacKay-Dunn | 26 |
| Gerry Brunk | 25 |
| Peter van der Velden | 25 |
- Stock Market
- Insiders
- Benjamin Rovinski
- Company connections
